Pingyuan Wang Selected Research

Pingyuan Wang Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 01/2017
9	Inflammation (Inflammations) 11/2021 - 01/2017
4	Infections 01/2021 - 01/2017
3	Channelopathies 01/2021 - 07/2020
3	Heart Failure 01/2020 - 01/2017
2	Triple Negative Breast Neoplasms 03/2024 - 12/2018
2	Lung Diseases (Lung Disease) 01/2021 - 11/2018
2	Nervous System Diseases (Neurological Disorders) 12/2017 - 01/2017
1	Cognitive Dysfunction 02/2024
1	Pathologic Processes 02/2024
1	Psychotic Disorders (Schizoaffective Disorder) 02/2024
1	Schizophrenia (Dementia Praecox) 02/2024
1	Huntington Disease (Huntington's Disease) 02/2024
1	Cerebral Malaria 12/2023
1	Gliosis 12/2023
1	Bites and Stings (Sting) 01/2023
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Myocardial Infarction 01/2020
1	Cardiotoxicity 01/2020
1	Pulmonary Hypertension 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Heart Valve Diseases (Valvular Heart Disease) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Atherosclerosis 01/2020
1	Pain (Aches) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Respiratory Syncytial Virus Infections 11/2018
1	Obesity 10/2018
1	Weight Gain 10/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2017
7	erythromycin propionate-N-acetylcysteinateIBA 03/2024 - 01/2017
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2023 - 01/2023
2	von Willebrand FactorIBA 11/2021 - 09/2020
2	Cyclic AMP Receptors (Cyclic AMP Receptor)IBA 11/2021 - 09/2020
2	Adenosine Monophosphate (AMP)IBA 09/2020 - 01/2019
1	matrigelIBA 03/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024
1	Cyclic AMP (AMP, Cyclic)IBA 02/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 12/2023
1	estropipate (Ogen)FDA LinkGeneric 12/2023
1	FibrinIBA 12/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Interferon Type IIBA 01/2023
1	pyridineIBA 07/2021
1	LigandsIBA 07/2021
1	MAY0132IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	fibroblast growth factor 14IBA 10/2020
1	Ligases (Synthetase)IBA 01/2020
1	Sirtuin 1IBA 01/2020
1	UbiquitinIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2019
1	AnkyrinsIBA 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanolIBA 01/2019
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2019
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 01/2019
1	EnzymesIBA 01/2019
1	aziridonin 44IBA 12/2018
1	oridoninIBA 12/2018
1	VaccinesIBA 11/2018
1	neuromedin UIBA 10/2018
1	NeuropeptidesIBA 10/2018
1	CytokinesIBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017

Therapy/Procedure

4	Therapeutics 05/2021 - 01/2017
1	Spinal Injections 01/2019